Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Treasury Shares (2016 - 2026)

Pharma-Bio Serv's Treasury Shares history spans 12 years, with the latest figure at $580967.0 for Q1 2026.

  • For Q1 2026, Treasury Shares rose 6.05% year-over-year to $580967.0; the TTM value through Jan 2026 reached $580967.0, up 6.05%, while the annual FY2025 figure was $579286.0, 5.74% up from the prior year.
  • Treasury Shares reached $616780.0 in Q1 2026 per PBSV's latest filing, up from $613680.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $616780.0 in Q1 2026 to a low of $484329.0 in Q1 2022.
  • Average Treasury Shares over 5 years is $552146.9, with a median of $556529.0 recorded in 2024.
  • Peak YoY movement for Treasury Shares: rose 26.78% in 2022, then grew 0.75% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $502236.0 in 2022, then grew by 6.84% to $536580.0 in 2023, then grew by 2.1% to $547843.0 in 2024, then rose by 5.74% to $579286.0 in 2025, then grew by 0.29% to $580967.0 in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Treasury Shares are $580967.0 (Q1 2026), $579286.0 (Q4 2025), and $570084.0 (Q3 2025).